Baseline patient factors impact on the clinical efficacy of benralizumab for severe asthma
Crossref DOI link: https://doi.org/10.1183/13993003.00936-2018
Published Online: 2018-08-23
Published Print: 2018-10
Update policy: https://doi.org/10.1183/ers-crossmark-policy
Bleecker, Eugene R.
Wechsler, Michael E.
FitzGerald, J. Mark
Menzies-Gow, Andrew
Wu, Yanping
Hirsch, Ian
Goldman, Mitchell
Newbold, Paul
Zangrilli, James G.
Funding for this research was provided by:
AstraZeneca